GSK settles second Zantac case in a month in California amid slew of US litigation

Firm wishes to avoid ‘protracted litigation’ with confidential settlement | Counsel for GSK told Delaware judge in January that lawsuits are ‘way ahead of the science’.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

GSK presses court to deny Teva’s ‘skinny label’ petition

25 August 2022 Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.

Generics

GSK responds to Teva’s ‘skinny’ label rehearing petition

9 December 2021 Following a substantial push from generics companies to reverse the GSK v Teva “skinny” label ruling, GlaxoSmithKilne has added its response to the petition to rehear the case yet again.

More on this story

Big Pharma

GSK presses court to deny Teva’s ‘skinny label’ petition

25 August 2022 Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.

Generics

GSK responds to Teva’s ‘skinny’ label rehearing petition

More on this story

Big Pharma

GSK presses court to deny Teva’s ‘skinny label’ petition

25 August 2022 Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.

Generics

GSK responds to Teva’s ‘skinny’ label rehearing petition